ELIXIRGEN THERAPEUTICS Trademark

Trademark Overview

On Wednesday, December 1, 2021, a trademark application was filed for ELIXIRGEN THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ELIXIRGEN THERAPEUTICS trademark a serial number of 97150473. The federal status of this trademark filing is REQUEST FOR SECOND EXTENSION - FILED as of Friday, April 19, 2024. This trademark is owned by Elixirgen Therapeutics, Inc.. The ELIXIRGEN THERAPEUTICS trademark is filed in the Advertising, Business and Retail Services category with the following description:

Retail store services featuring pharmaceutical drugs and chemical preparations for cell and gene therapy
elixirgen therapeutics

General Information

Serial Number97150473
Word MarkELIXIRGEN THERAPEUTICS
Filing DateWednesday, December 1, 2021
Status719 - REQUEST FOR SECOND EXTENSION - FILED
Status DateFriday, April 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2023

Trademark Statements

Goods and ServicesRetail store services featuring pharmaceutical drugs and chemical preparations for cell and gene therapy
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, December 6, 2021
Primary Code035
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History

Party NameElixirgen Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBaltimore, US 21205
Party NameElixirgen Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBaltimore, US 21205

Trademark Events

Event DateEvent Description
Saturday, December 4, 2021NEW APPLICATION ENTERED
Monday, December 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 10, 2022ASSIGNED TO EXAMINER
Monday, September 19, 2022NON-FINAL ACTION WRITTEN
Monday, September 19, 2022NON-FINAL ACTION E-MAILED
Monday, September 19, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 19, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 19, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 28, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 22, 2023DIVISIONAL REQUEST RECEIVED
Tuesday, August 22, 2023TEAS REQUEST TO DIVIDE RECEIVED
Monday, August 28, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 12, 2023DIVISIONAL PROCESSING COMPLETE
Wednesday, September 13, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 13, 2023SOU EXTENSION 1 FILED
Thursday, September 14, 2023SOU EXTENSION 1 GRANTED
Friday, September 15, 2023CORRECTED NOA E-MAILED
Friday, September 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 19, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 19, 2024SOU EXTENSION 2 FILED
Friday, April 19, 2024SOU EXTENSION 2 GRANTED
Saturday, April 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

therapeutics elixirgen preparations cell gene therapy chemical drugs store services featuring pharmaceutical